T. Rowe Price Associates’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.23M Buy
85,577
+4,992
+6% +$71.7K ﹤0.01% 1886
2025
Q1
$1.17M Buy
80,585
+3,192
+4% +$46.3K ﹤0.01% 1874
2024
Q4
$1.02M Buy
77,393
+6,753
+10% +$88.7K ﹤0.01% 1953
2024
Q3
$819K Buy
70,640
+882
+1% +$10.2K ﹤0.01% 2048
2024
Q2
$527K Sell
69,758
-17,611
-20% -$133K ﹤0.01% 2174
2024
Q1
$877K Buy
87,369
+3,669
+4% +$36.8K ﹤0.01% 1970
2023
Q4
$779K Buy
83,700
+14,085
+20% +$131K ﹤0.01% 1986
2023
Q3
$885K Buy
69,615
+13,909
+25% +$177K ﹤0.01% 1851
2023
Q2
$792K Buy
55,706
+1,243
+2% +$17.7K ﹤0.01% 1912
2023
Q1
$813K Buy
54,463
+6,276
+13% +$93.7K ﹤0.01% 1885
2022
Q4
$716K Sell
48,187
-10,922
-18% -$162K ﹤0.01% 1959
2022
Q3
$976K Sell
59,109
-2,404
-4% -$39.7K ﹤0.01% 1761
2022
Q2
$1.29M Sell
61,513
-7,364
-11% -$155K ﹤0.01% 1773
2022
Q1
$1.62M Buy
68,877
+4,249
+7% +$99.8K ﹤0.01% 1773
2021
Q4
$1.76M Sell
64,628
-3,896
-6% -$106K ﹤0.01% 1773
2021
Q3
$1.95M Sell
68,524
-1,754
-2% -$49.9K ﹤0.01% 1737
2021
Q2
$2.12M Sell
70,278
-4,960
-7% -$150K ﹤0.01% 1712
2021
Q1
$1.92M Sell
75,238
-2,509
-3% -$63.9K ﹤0.01% 1740
2020
Q4
$1.91M Sell
77,747
-20,281
-21% -$498K ﹤0.01% 1653
2020
Q3
$1.6M Buy
98,028
+5,228
+6% +$85.1K ﹤0.01% 1622
2020
Q2
$1.59M Sell
92,800
-3,368
-4% -$57.6K ﹤0.01% 1601
2020
Q1
$1.12M Buy
96,168
+20,099
+26% +$234K ﹤0.01% 1658
2019
Q4
$2.11M Sell
76,069
-2,960,050
-97% -$82.3M ﹤0.01% 1582
2019
Q3
$68.7M Sell
3,036,119
-1,704,368
-36% -$38.6M 0.01% 744
2019
Q2
$120M Sell
4,740,487
-2,149,278
-31% -$54.2M 0.02% 600
2019
Q1
$187M Sell
6,889,765
-1,911,086
-22% -$51.9M 0.03% 488
2018
Q4
$290M Buy
8,800,851
+377,903
+4% +$12.5M 0.05% 338
2018
Q3
$393M Sell
8,422,948
-137,732
-2% -$6.43M 0.06% 322
2018
Q2
$371M Sell
8,560,680
-1,004,843
-11% -$43.5M 0.06% 326
2018
Q1
$532M Sell
9,565,523
-342,166
-3% -$19M 0.08% 236
2017
Q4
$529M Sell
9,907,689
-846,658
-8% -$45.2M 0.09% 239
2017
Q3
$464M Sell
10,754,347
-1,427,534
-12% -$61.6M 0.08% 266
2017
Q2
$735M Buy
12,181,881
+2,433,378
+25% +$147M 0.13% 178
2017
Q1
$676M Buy
9,748,503
+337,675
+4% +$23.4M 0.13% 187
2016
Q4
$627M Buy
9,410,828
+1,376,773
+17% +$91.8M 0.12% 190
2016
Q3
$532M Buy
8,034,055
+508,260
+7% +$33.7M 0.11% 216
2016
Q2
$545M Buy
7,525,795
+46,575
+0.6% +$3.37M 0.12% 208
2016
Q1
$483M Buy
7,479,220
+27,539
+0.4% +$1.78M 0.1% 224
2015
Q4
$534M Buy
7,451,681
+1,870,435
+34% +$134M 0.11% 197
2015
Q3
$429M Buy
5,581,246
+36,480
+0.7% +$2.8M 0.1% 237
2015
Q2
$411M Buy
5,544,766
+2,940
+0.1% +$218K 0.08% 258
2015
Q1
$402M Buy
5,541,826
+41,230
+0.7% +$2.99M 0.08% 277
2014
Q4
$364M Buy
5,500,596
+14,020
+0.3% +$927K 0.08% 296
2014
Q3
$301M Sell
5,486,576
-96,582
-2% -$5.29M 0.07% 329
2014
Q2
$325M Sell
5,583,158
-8,133
-0.1% -$473K 0.07% 324
2014
Q1
$347M Sell
5,591,291
-409
-0% -$25.4K 0.08% 295
2013
Q4
$298M Buy
5,591,700
+19,100
+0.3% +$1.02M 0.07% 330
2013
Q3
$280M Sell
5,572,600
-33,000
-0.6% -$1.66M 0.07% 324
2013
Q2
$257M Buy
+5,605,600
New +$257M 0.07% 336